This is the authors' abstract. We don't add key points for this paper.
Purpose: To retrospectively study our risk factors for breast cancer recurrence and compare them with data from the literature. Materials and Methods: Through the analysis of 310 patients admitted to the radiotherapy department of the Mohammed V Military Teaching Hospital in Rabat between January 2009 and December 2015, we identified local, locoregional and / or systemic recurrence factors. Results: The mean age was 49.15 10.37 years, the mean parity was 3.3 2, 43.5% were postmenopausal, 18.3% had a family history of breast cancer, and 41.3% used oral contraception. According to the TNM classification, 49.8% were classified as stage IIA. Invasive ductal carcinoma was predominant (82.6%). For the histo-prognosis grade of Scarf-Bloom and Richardson (SBR), 91% of patients were classified as SBR II and III. Lymphovascular invasion (LVI) were positive in 44.2%, and hormone receptors (HR) were positive in 75.8%. Lymph node involvement 4 nodes was noted in 28.5% of patients. In univariate analysis, the presence of LVI (p <0.001), N4 (p <0.025) and RH negative (p <0.021) were statistically significant risk factors for recurrence. While in multivariate analysis, only EV (p <0.035) and HR negativity (p <0.012) were statistically significant. Conclusion: Our study highlights known risk factors; namely massive ganglionic invasion, lymphovascular invasion and hormone receptors. Other factors must be studied to improve the future management of our patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Maghous et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: